Making improvements in life possible
QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.
Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows.
QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics).
As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.
Life science research, Molecular diagnostics, Applied testing (forensics, food safety testing, veterinary medicine), Pharmaceutical research, and bioinformatics
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Servier Pharmaceuticals Pharmaceutical, Pharmaceutical Manufacturing | Other 28 Feb 2023 | | |
Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 1 Mar 2023 | | |
NYSE Finance, Financial Services | NYSE Finance, Financial Services | Other 7 Dec 2023 | | |
Deutsche Börse Finance, Financial Services | Deutsche Börse Finance, Financial Services | Other 30 Jun 2023 | |